Cargando…

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective

SIMPLE SUMMARY: Immunotherapy is achieving impressive results in the treatment of several cancers. While the main strategies aim to re-invigorate the specific lymphocyte anti-tumor response, many studies underline that altered myeloid cell frequency and functions can dramatically interfere with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bleve, Augusto, Consonni, Francesca Maria, Porta, Chiara, Garlatti, Valentina, Sica, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833347/ https://www.ncbi.nlm.nih.gov/pubmed/35158779 http://dx.doi.org/10.3390/cancers14030510

Ejemplares similares

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)

Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
por: Bleve, Augusto, et al.
Publicado: (2020)

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
por: Bleve, Augusto, et al.
Publicado: (2022)

Immunometabolic interference between cancer and COVID-19
por: Consonni, Francesca Maria, et al.
Publicado: (2023)

SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities
por: Sangaletti, Sabina, et al.
Publicado: (2019)

Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
por: Najjar, Yana G., et al.
Publicado: (2013)

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
por: Bronte, Vincenzo, et al.
Publicado: (2016)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
por: Wang, Yufei, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells for cancer therapy
por: Tang, Hongchao, et al.
Publicado: (2021)

Influence of Innate Immunity on Cancer Cell Stemness
por: Pastò, Anna, et al.
Publicado: (2020)

Implications of metabolism-driven myeloid dysfunctions in cancer therapy
por: Strauss, Laura, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
por: Law, Andrew M. K., et al.
Publicado: (2020)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives
por: Koinis, Filippos, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
por: Lu, Li-Chun, et al.
Publicado: (2019)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021)

Editorial: Myeloid Derived Suppressor Cells as Disease Modulators
por: Finn, Olivera J., et al.
Publicado: (2020)

Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation
por: Antonarelli, Gabriele, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities
por: Botta, Cirino, et al.
Publicado: (2014)

New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
por: Wesolowski, Robert, et al.
Publicado: (2013)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
por: Mabuchi, Seiji, et al.
Publicado: (2021)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
por: Fan, Rong, et al.
Publicado: (2022)

The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
por: Ren, Ruiyang, et al.
Publicado: (2023)

The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance
por: Mola, Silvia, et al.
Publicado: (2020)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

In Brief: Myeloid‐derived suppressor cells in cancer
por: Solito, S, et al.
Publicado: (2017)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
por: Sieminska, Izabela, et al.
Publicado: (2020)

Myeloid-derived suppressor cells: Cellular missiles to target tumors
por: Chandra, Dinesh, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
por: Siemińska, Izabela, et al.
Publicado: (2022)

LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer
por: Zhao, Ting, et al.
Publicado: (2023)

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a2l31nhufgpvug4lf741hrr9vl